Selected Publications
- T Hendrikx, S Lang, et al. Hepatic pIgR-mediated secretion of IgA limits bacterial translocation and prevents ethanol-induced liver disease in mice. Gut 2023 Jan 23;gutjnl-2022-328265. doi: 10.1136/gutjnl-2022-328265
- T Hendrikx*, F Porsch*, et al. Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH. J of Hepatology 2022 Nov;77(5):1373-1385. doi: 10.1016/j.jhep.2022.06.004.
- T Hendrikx, CJ Binder. Oxidation-specific epitopes in non-alcoholic fatty liver disease. Front. Endocrinol., 2020 December. doi.org/10.3389/fendo.2020.607011
- T Hendrikx, B Schnabl. Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease. J Intern Med. 2019 Mar 14. doi: 10.1111/joim.12892
- T Hendrikx, et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. Gut. 2018 Nov 17. pii: gutjnl-2018-317232. doi: 10.1136/gutjnl-2018-317232.
- C JL Busch*, T Hendrikx*, et al. Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice. Hepatology, 2016 Dec 16. doi: 10.1002/hep.28970.
- T Hendrikx, et al. Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease. BMC Med. 2016 Jul 22;14(1):107 doi: 10.1186/s12916-016-0652-0
- S Gruber, T Hendrikx, et al. Sialic acid-binding immunoglobulin-like lectin G promotes atherosclerosis and liver inflammation by suppressing the protective functions of B-1 cells. Cell Rep. 2016 Mar 15;14(10):2348-61. doi: 10.1016/j.celrep.2016.02.027.
- T Hendrikx, et al. Kupffer cell specific Cyp27a1 overexpression reduces hepatic inflammation in hyperlipidemic Ldlr-/- mice. J Hepatol. 2015 Feb;62(2):430-6. doi: 10.1016/j.jhep.2014.09.027.